Organic Radicals for Tumor Therapy.
Organic radical materials have emerged as promising candidates for tumor therapy, owing to their distinctive open-shell electronic structures and superior photophysical characteristics.
APA
Yang W, Du X (2026). Organic Radicals for Tumor Therapy.. Langmuir : the ACS journal of surfaces and colloids, 42(1), 78-92. https://doi.org/10.1021/acs.langmuir.5c05143
MLA
Yang W, et al.. "Organic Radicals for Tumor Therapy.." Langmuir : the ACS journal of surfaces and colloids, vol. 42, no. 1, 2026, pp. 78-92.
PMID
41449653
Abstract
Organic radical materials have emerged as promising candidates for tumor therapy, owing to their distinctive open-shell electronic structures and superior photophysical characteristics. Through chemical modifications and nanotechnological approaches, these materials have paved the way for precision medicine, showcasing robust spin-coupling phenomena and near-infrared light absorption properties. Leveraging these attributes, organic radicals have demonstrated enhanced therapeutic outcomes in photothermal therapy, photodynamic therapy, and other novel modalities. This review provides an overview of the applications of organic radicals in tumor therapy and also highlights existing hurdles and future prospects of organic radicals in cancer treatment.
MeSH Terms
Humans; Neoplasms; Free Radicals; Photochemotherapy; Antineoplastic Agents; Animals
같은 제1저자의 인용 많은 논문 (5)
- Prognostic Impact of the Level of Minimal Residual Disease Prior to Allogeneic Hematopoietic Stem Cell Transplantation on Pediatric Patients With Acute Lymphoblastic Leukemia: A 10-Year Single-Center Study.
- A multi-scale feature fusion of deep learning network for classifying acute leukemia genetic subtypes from blood smear images.
- Comment on: "Indocyanine green fluorescence in pelvic lymph node dissection during laparoscopic radical prostatectomy: a randomized controlled trial".
- Inferring germline pharmacogenomics from tumor transcriptome.
- TDO2-Associated Tryptophan Metabolism Correlates with Impaired Tertiary Lymphoid Structure Maturation and Reduced B Cell Class Switching in Breast Cancer.